tradingkey.logo
tradingkey.logo
Search

vTv Therapeutics Inc

VTVT
Add to Watchlist
30.450USD
-0.130-0.42%
Market hours 09/24, 10:08ET
119.97MMarket Cap
LossP/E TTM

VTVT Financials

See vTv Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
119.97M
Dividend TTM
0.00
P/E TTM
-62.94
EPS TTM
-0.48
Revenue
0.00
Net Profit
-18.46M
ROE
4.60%
ROA
-1.11%

vTv Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
-1.05/-0.99
Revenue / Forecast
0.00/300.00K

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
-14.61%-1.05
351.42%1.94
-3.93%-0.57
-23.17%-1.08
-13.46%-0.92
34.15%-0.77
64.66%-0.55
73.16%-0.88
70.67%-0.81
46.81%-1.17
32.94%-1.56
---3.27
---2.76
---2.21
---2.33
---7.94
----
----
----
----
Revenue
--0.00
--36.84M
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--17.00K
--0.00
--0.00
--1.00M
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
0.00%9.00K
-100.00%0.00
0.00%9.00K
102.63%2.00M
-99.86%9.00K
42757.14%3.00M
Net Profit
-115.91%-13.05M
573.96%24.13M
-96.42%-7.14M
-81.85%-8.70M
-16.72%-6.05M
-4.67%-5.09M
-4.49%-3.63M
28.12%-4.78M
7.81%-5.18M
-8.14%-4.87M
26.70%-3.48M
-56.16%-6.65M
-78.32%-5.62M
35.79%-4.50M
32.70%-4.75M
-292.00%-4.26M
-418.26%-3.15M
-65.22%-7.01M
-726.20%-7.05M
29.09%-1.09M
Net Margin
----
--65.51%
----
----
----
----
---26100.00%
----
----
---601.90%
----
----
----
----
---67666.67%
---944.90%
----
----
----
----
Gross Margin
----
--100.00%
----
----
----
----
--100.00%
----
----
--100.00%
----
----
----
----
--100.00%
--100.00%
----
----
----
----
Debt to assets ratio
----
----
----
--0.33%
----
----
-100.00%0.00%
-100.00%0.00%
--0.00%
--0.00%
157.23%1.73%
--3.17%
--0.00%
--0.00%
--0.67%
--1.57%
----
----
----
----
Revenue
--0.00
--36.84M
-100.00%0.00
--0.00
--0.00
-100.00%0.00
--17.00K
--0.00
--0.00
--1.00M
-100.00%0.00
--0.00
-100.00%0.00
-100.00%0.00
0.00%9.00K
-100.00%0.00
0.00%9.00K
102.63%2.00M
-99.86%9.00K
42757.14%3.00M
Operating profit
-80.42%-13.93M
457.73%23.26M
-61.18%-7.88M
-64.45%-10.70M
-7.91%-7.72M
-15.57%-6.50M
-3.93%-4.89M
-21.20%-6.51M
10.56%-7.16M
24.24%-5.63M
25.79%-4.71M
5.64%-5.37M
-98.66%-8.00M
-14.60%-7.43M
42.90%-6.34M
-254.90%-5.69M
13.77%-4.03M
-51.43%-6.48M
-707.05%-11.11M
43.40%-1.60M
Net Profit
-115.91%-13.05M
573.96%24.13M
-96.42%-7.14M
-81.85%-8.70M
-16.72%-6.05M
-4.67%-5.09M
-4.49%-3.63M
28.12%-4.78M
7.81%-5.18M
-8.14%-4.87M
26.70%-3.48M
-56.16%-6.65M
-78.32%-5.62M
35.79%-4.50M
32.70%-4.75M
-292.00%-4.26M
-418.26%-3.15M
-65.22%-7.01M
-726.20%-7.05M
29.09%-1.09M
Current assets
232.10%87.59M
209.59%98.81M
135.86%89.89M
131.52%99.46M
-42.91%26.37M
-40.76%31.92M
257.63%38.11M
324.28%42.96M
231.47%46.20M
161.17%53.87M
-60.67%10.66M
-64.82%10.13M
-54.46%13.94M
51.54%20.63M
73.45%27.09M
29.82%28.78M
171.55%30.61M
47.62%13.61M
116.51%15.62M
502.80%22.17M
Total current liabilities
32.52%7.02M
59.43%6.88M
27.81%6.64M
58.20%10.16M
-24.19%5.29M
-51.62%4.32M
-51.07%5.20M
-37.48%6.42M
-24.78%6.99M
4.56%8.92M
37.77%10.62M
37.61%10.28M
-5.49%9.29M
-32.82%8.53M
-9.30%7.71M
35.52%7.47M
94.21%9.82M
146.03%12.70M
32.99%8.50M
-33.58%5.51M
Total assets
231.19%87.59M
208.53%98.81M
134.93%89.90M
130.50%99.49M
-43.07%26.45M
-40.89%32.03M
247.30%38.27M
189.23%43.16M
107.16%46.46M
87.95%54.18M
-66.85%11.02M
-57.98%14.92M
-39.37%22.43M
42.82%28.83M
30.48%33.24M
12.99%35.52M
70.77%36.99M
20.48%20.18M
72.25%25.47M
346.13%31.43M
Total liabilities
-62.73%8.96M
-61.72%8.85M
6.25%25.46M
14.65%28.95M
-7.60%24.04M
-17.97%23.13M
-32.87%23.96M
-37.12%25.25M
-45.46%26.02M
-41.28%28.20M
-18.83%35.70M
-22.90%40.16M
4.82%47.71M
69.81%48.02M
24.89%43.98M
-1.69%52.09M
-34.49%45.52M
-61.28%28.28M
-62.89%35.21M
-9.31%52.98M
Total equity
3169.52%78.63M
911.12%89.96M
350.58%64.44M
293.81%70.54M
-88.23%2.40M
-65.76%8.90M
157.95%14.30M
170.99%17.91M
180.83%20.44M
235.41%25.99M
-129.80%-24.68M
-52.29%-25.23M
-196.54%-25.28M
-137.14%-19.19M
-10.27%-10.74M
23.10%-16.57M
82.17%-8.53M
85.62%-8.09M
87.84%-9.74M
58.06%-21.55M
Net operating income
-124.59%-11.44M
260.96%9.15M
-91.73%-9.25M
18.64%-5.22M
24.28%-5.09M
22.47%-5.69M
-65.58%-4.83M
-32.77%-6.42M
-9.11%-6.73M
-41.99%-7.33M
57.65%-2.91M
45.24%-4.83M
-973.51%-6.17M
-405.97%-5.17M
-7.22%-6.88M
-145.60%-8.83M
117.66%706.00K
80.73%-1.02M
-190.10%-6.42M
33.86%-3.59M
Net investment
----
----
----
----
----
--0.00
----
----
----
----
--4.40M
--0.00
----
----
--0.00
--0.00
---21.00K
----
----
----
Net financing
----
----
---321.00K
3058.91%77.80M
---42.00K
-100.00%0.00
100.00%0.00
420.72%2.46M
--0.00
324.73%50.14M
-107.69%-282.00K
-92.50%473.00K
-100.00%0.00
4711.72%11.81M
1278.57%3.67M
-48.86%6.30M
-21.05%5.04M
-103.20%-256.00K
-95.66%266.00K
1318.30%12.32M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What are the current assets of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its current assets were 89.89M, with a year-on-year change of 135.86.

What are the total assets of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its total assets of vTv Therapeutics Inc were 89.90M, with a year-on-year change of 134.93.

What are the total liabilities of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its total liabilities of vTv Therapeutics Inc were 25.46M, with a year-on-year change of 6.25.

What is the total equity of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its total equity of vTv Therapeutics Inc was 64.44M, with a year-on-year change of 350.58.

What is the net operating income of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its net operating income of vTv Therapeutics Inc was -32.81M, with a year-on-year change of -35.68.

What is the net financing of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its net financing of vTv Therapeutics Inc was 77.44M, with a year-on-year change of 47.21.

What is the Earnings Per Share (EPS) of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.20, with a year-on-year change of -0.10.

What is the net income of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its net income was -26.97M, with a year-on-year change of -46.11.

What is the Return on Assets (ROA) of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.50, with a year-on-year change of 47.36.

What is the operating profit of vTv Therapeutics Inc?

According to vTv Therapeutics Inc's FY2025 earnings report, its operating profit was -32.81M, with a year-on-year change of -35.68.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.